Keryx Biopharmaceuticals (KERX) gapped up at the open Monday and climbed during the first half hour of trade. The stock has taken out the highs of the morning in the last few minutes and is now up 1.02 at $4.72 on the highest volume of the year.
Keryx Biopharmaceuticals has surged past the upper end of a one-month range this morning and has set over a 7-month high.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.